Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-06 · accession 0001209191-22-060588 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-09 | 2022-12-06 | TXMD | Bernick Brian | Co-CEO | M - OptEx | $0.00 | +3,167 | 5,127 | +162% | $0 |
| DM | 2022-12-09 | 2022-12-06+ | TXMD | Bernick Brian | Co-CEO | S - Sale+OE | $5.27 | -1,255 | 4,192 | -23% | -$6,619 |
| D | 2022-12-09 | 2022-12-06 | TXMD | Bernick Brian | Co-CEO | M - OptEx | $0.00 | -3,167 | 10.5K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-06 | M | A | 3,167 | $0.00 | 5,127 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 3,167 shares of issuer common stock in settlement of restricted stock units (RSUs). |
| 2 | Common | Common Stock | 2022-12-09 | S | D | 320 | $6.31 | 3,872 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-06 | S | D | 935 | $4.92 | 4,192 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.66 to $5.37, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. |
| 4 | Derivative | Restricted Stock Units | 2022-12-06 | M | D | 3,167 | $0.00 | 10,517 | D | $0.00 · — to — | 3,167 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 3,167 shares of issuer common stock in settlement of restricted stock units (RSUs). (F6) The RSUs shall vest as as follows: 5,200 RSUs shall vest in three equal installments annually beginning on March 23, 2023; 1,664 RSUs shall vest in three equal installments annually beginning on September 29, 2022; 3,200 RSUs shall vest in two equal installments annually beginning on July 1, 2023; and 1,010 RSUs shall vest on March 30, 2023. Also includes 2,610 RSUs that were previously vested but were not settled until December 6, 2022. |